Colon cancer: Adding immunotherapy may halve death, recurrence rate
Adding immunotherapy to chemotherapy after surgery for stage 3 colon cancer may help decrease recurrence and death rate by 50%, a new study indicates.
Read More
Tags
Leave a comment
Comments ({{ storyCommentsCount }})
{{comment.name}}
{{comment.created | tsdate:'MMMM dd, yyyy'}}
{{comment.created | tsdate:'h:mm a'}}
{{comment.comment}}
{{replyComments.name}}
{{replyComments.created | tsdate:'MMMM dd, yyyy'}}
{{replyComments.created | tsdate:'h:mm a'}}
{{replyComments.comment }}
